Patent: 8,263,125
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 8,263,125
Title: | Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients |
Abstract: | A dosage form comprising of a high dose, high solubility active ingredient as modified release and a low dose active ingredient as immediate release where the weight ratio of immediate release active ingredient and modified release active ingredient is from 1:10 to 1:15000 and the weight of modified release active ingredient per unit is from 500 mg to 1500 mg; a process for preparing the dosage form. |
Inventor(s): | Vaya; Navin (Gujarat, IN), Karan; Rajesh Singh (Gujarat, IN), Nadkarni; Sunil Sadanand (Gujarat, IN), Gupta; Vinod Kumar (Gujarat, IN) |
Assignee: | Torrent Pharmaceuticals Limited (Ahmedabad, IN) |
Application Number: | 11/134,633 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,263,125 |
Patent Claims: | see list of patent claims |
Details for Patent 8,263,125
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 01/15/1974 | ⤷ Try a Trial | 2022-08-05 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 12/27/1984 | ⤷ Try a Trial | 2022-08-05 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 02/15/1985 | ⤷ Try a Trial | 2022-08-05 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 02/16/1990 | ⤷ Try a Trial | 2022-08-05 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |